Trevena, Inc. (TRVN)

OTCMKTS · Delayed Price · Currency is USD

0.0120

-0.0061 (-33.52%)

Oct 7, 2025, 3:40 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Novel Medicines for Central Nervous System Disorders	3.13M	Log In	Log In	Log In	Log In	Upgrade
Novel Medicines for Central Nervous System Disorders Growth	-847.61%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	3.13M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-847.61%	Log In	Log In	Log In	Log In	Upgrade